Skip to main content
Clinical Trials/NCT05986825
NCT05986825
Completed
N/A

Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)

University Hospital, Brest1 site in 1 country60 target enrollmentAugust 29, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hidradenitis Suppurativa
Sponsor
University Hospital, Brest
Enrollment
60
Locations
1
Primary Endpoint
Validation of the questionnaire
Status
Completed
Last Updated
last year

Overview

Brief Summary

Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.

Registry
clinicaltrials.gov
Start Date
August 29, 2023
End Date
December 22, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥18 years
  • Patient with Verneuil disease
  • Beneficiary of or affiliated to a social security insurance
  • Participation agreement

Exclusion Criteria

  • Patients physically or mentally unable to complete questionnaires.
  • Refusal to participate
  • Patient under legal protection (guardianship, curatorship) or deprived of liberty

Outcomes

Primary Outcomes

Validation of the questionnaire

Time Frame: During the visit and 1 week later

Study Sites (1)

Loading locations...

Similar Trials